ScholarIQanswers from OpenAlex

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway

PaperCitations, authors & open-access status

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway have?

ScholarIQcitation count

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway has 112 citations in the OpenAlex counts ScholarIQ stores.

When was Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway published?

ScholarIQyear

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway has 2018 year in the ScholarIQ index.

What is the open-access status of Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway?

ScholarIQoa status

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway has gold oa status in the ScholarIQ index.

What is the DOI of Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway?

ScholarIQdoi

The DOI for Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway is on the source record.

What is the PMID of Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway?

ScholarIQpmid

The PMID for Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway is on the source record.

What is the OpenAlex record for Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway?

ScholarIQopenalex

The OpenAlex for Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial